6 Nov 2017 BAARN (Boston Area Antimicrobial Resistance Network) + 7-8 Nov BARDA Industry Days

Dear All:

Early November will be busy! First, BAARN is having their annual meeting in the Boston area on 6 Nov. See below a note from Michael Gilmore with details. If you are in Boston on that day, I highly recommend this meeting as a superb scientific event & networking opportunity.

Second, you can then go from BAARN to BARDA’s Industry Days in DC on 7-8 Nov. Here’s the registration link for more details. This is an opportunity to learn about BARDA’s strategic goals for FY18 and beyond while networking with members of ASPR, BARDA, AMCG and other government and industry stakeholders. If you are consider US government funding, this is a great way to learn about working with BARDA and its USG partners.

All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Chief Strategy Officer, CARB-X | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: https://13.43.35.2/blog/

Mike writes: Tickets for the 2017 annual Boston Area Antibiotic Resistance Network meeting are now available at this link. The event will be on 6 Nov 2017 at the American Academy of Arts and Science’s Norton Woods Conference Center, adjacent to the Harvard campus (200 Beacon St., Somverville MA). The auditorium is limited to 200 attendees, so register early and notify friends and associates you know to be interested.

In response to feedback from last year, there will be more opportunity for 1-on-1 networking throughout the day. There will also be a rapid fire session for new biotechs to introduce their new efforts to the community.

The program:
8:00 – 8:30 Registration
8:30  Welcome

8:35 Session I: Advances in new therapeutics
10:15 – 11:00 Networking over coffee

11:00  Session II: Advances in alternatives to antibiotics for managing host microbe interactions
12:15 Lunch and more networking

2:00  Session III: Advances in Diagnostics
3:40 – 4:00 Short Break

4:00  Federal resources that can help (NIH Research Resources & Translational. Research DMID)
4:30  Short poster pitches from select treatment or diagnostic biotech startups

5:15 Networking and posters
7:00 Adjourn

​——————————
Upcoming meetings of interest to the AMR community:

Share

EPA (part 5): Interagency Framework on AMR Risks of Antibacterial and Antifungal Pesticides

This is the fifth of a 5-part newsletter series. There is an initial 27 Sep 2023 newsletter introducing the EPA concept note, a second (28 Sep 2023) newsletter that expands on the EPA concept note, a third (12 Jan 2024) newsletter about ending the use of streptomycin spray on citrus crops, and a 4th newsletter (27 Jan 2024) containing some additional resources. Dear All, Excitingly, the US EPA

HLM on AMR at UNGA: The end of the beginning

Aside: Please refer to our UNGA 2024 webpage for additional post-HLM notes and updates. Dear All (and with thanks to Damiano for co-authoring), Last week in NYC, the UN General Assembly (UNGA) and all its surrounding activities created a lot of energy (not to mention a giant traffic jam)! After a series of side meetings

Without action, AMR costs go from $66b to $159b/yr by 2050

Dear All, A new paper from Anthony McDonnell and a team led by the Center for Global Development extends estimates of the health-related impact of AMR (e.g., death) to a consideration of the economic ($) cost of AMR. To follow the plot, here are the links you will need: The new paper: “Forecasting the Fallout

UN TV: You can watch the AMR High-Level Meeting at UNGA

Dear All, The AMR HLM (High-Level Meeting) at the UN General Assembly starts at 10a ET today.  You can watch it here on UN TV: https://webtv.un.org/en/asset/k11/k11knc6w2t Addendum: It’s available for replay at that same link. See also the 1 Oct 2024 newsletter for a review of the HLM. All best wishes, –jr John H. Rex, MD

Scroll to Top